System Transmission

Top Signal

100#1 JOB

Activity

2163Ripe

+917 today

System

Livenow

Terminal Asset View

stockNASDAQ

ALGS

$7.57+2.16%

Aligos Therapeutics Inc

Ripe

Official Site

Market value

24H Total Traded

Total supply

52-Week Range

Ripeness Index

79Ripe

Live Analysis Active

Company Mission

Aligos Therapeutics creates new drugs to treat liver diseases, such as hepatitis B and liver cancer. It works with doctors and hospitals to test these medicines in clinical trials. The company makes money by partnering with larger pharmaceutical firms and hopes to earn from drug sales if treatments get approved.

ALG

Industry Context

Aligos operates in the biotechnology industry, which focuses on developing new medical treatments through scientific research. This industry is known for high risk and high reward, as companies spend years testing drugs before they can be sold, and stock prices often move based on clinical trial results or regulatory decisions.

Scoring Terminal

Intelligence Pipeline Active

Algorithm Verified

Asset Diagnostics

ProtocolV2.1_TACTICAL

Technical Matrix

Scanning

86Matrix

Market Momentum

52.9— Holding Steady

Trend Strength

50— Active Setup

Momentum Engine

Accelerating

Velocity Score

Accelerating

StaticOptimal FlowMax Vel

Trading Activity

1.1x— Normal Volume

Today's Change

2.16%— Live Performance

Social Frequency

Listening

Social Freq

0.0x

Normal Vol

X/Twitter Activity

0.0x— Streaming

Reddit Buzz

0.0x— Synced

System Observation

ANALYSIS:Price energy is building quickly for a potential move. Bullish alignment confirmed.

Lat14ms

BufOK

Positive Catalysts

No active score modifiers detected

Risk Flags

52W Threshold-1

Price is extended significantly above 52-week highs.

Banana Farmer tracks 100's of signals to synthesize this proprietary score.

0Velocity

Awaiting Data

Social Intelligence Pulse.

Our engine is currently indexing ALGS across global social channels to detect early sentiment shifts and technical alignment.

XMonitoring

RedditMonitoring

WebMonitoring

Social GrowthPending

Signal CoverageInitializing

Signal Catalysts

Intelligence Narrative Connected

Updated 10:05 PM UTC

As-of 03-14-2026 21:50 UTC

Develops medicines to treat liver diseases and makes money by selling these treatments to hospitals and pharmacies.

Price dropped 2% yesterday but rose over three days, suggesting short-term volatility as traders react to news.

Biotech sector faces regulatory uncertainty, which can cause stock swings for companies like this developing new treatments.

Educational only. Not investment advice.

Precision Intelligence Model

Live Terminal Stream

Loading chart...